サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1628883

酵素創傷デブリードマンの世界市場：酵素の種類別・形状別・創傷の種類別・エンドユーザー別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2024年～2032年)

Enzymatic Wound Debridement Market, By Enzyme Type, By Form, By Wound Type, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 369 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
酵素創傷デブリードマンの世界市場：酵素の種類別・形状別・創傷の種類別・エンドユーザー別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2024年～2032年)
出版日: 2024年12月02日
発行: AnalystView Market Insights
ページ情報: 英文 369 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

酵素創傷デブリードマンの市場規模は2023年に8億7,700万米ドルとなり、2024年から2032年にかけて6.1%のCAGRで拡大

酵素創傷デブリードマンの市場力学

慢性疾患の有病率の上昇が酵素創傷デブリードマン市場の成長を促進

国際糖尿病連合によると、世界で4億6,000万人以上が罹患している糖尿病などの慢性疾患の有病率の増加により、酵素創傷デブリードマン市場は大きな成長を遂げています。コラゲナーゼのような製品を利用して壊死組織を選択的に除去する酵素創傷デブリードマンは、組織損傷を最小限に抑えて治癒を早めることができるため、支持を集めています。米国では、糖尿病の一般的な合併症である糖尿病性足潰瘍が糖尿病患者の約15%を占めており、効果的な創傷治療に対する需要が高まっています。さらに、酵素製剤の進歩によりデブリードマン製品の有効性が高まり、より入手しやすく手頃な価格になっています。政府や医療機関も創傷治療基準の向上に力を入れており、欧州では先進治療への認識とアクセスを高めることを目的とした取り組みが行われています。このような慢性疾患管理と効果的な創傷治癒療法への関心の高まりが、酵素的創傷デブリードマン市場の拡大を後押ししています。

酵素創傷デブリードマン市場：主な考察

リサーチアナリストの分析によると、世界市場は予測期間 (2024-2032年) に約6.1%のCAGRで毎年成長すると推定されます。

酵素の種類別では、コラゲナーゼベースが2023年に最大の市場シェアを示すと予測されています。

形状別では、2023年には軟膏剤が主要タイプとなっています。

創傷の種類別では、2023年には慢性創傷が主要タイプとなっています。

地域別では、北米が2023年の主要収益源でした。

酵素創傷デブリードマン市場：セグメンテーション分析

世界の酵素創傷デブリドメント市場は、酵素の種類、形態、創傷の種類、エンドユーザー、地域に基づいてセグメント化されます。

市場は酵素の種類別に4つのカテゴリーに分けられます：コラゲナーゼベース、パパインベース、トリプシンベース、タンパク質分解酵素です。コラゲナーゼベースの酵素デブリードメントは、壊死組織のコラーゲンを分解する有効性により市場をリードしています。パパインベースの酵素がこれに続き、創傷ケアにより優しい選択肢を提供しています。タンパク質分解酵素とトリプシンベースの製品はあまり使用されていないが、用途が拡大しています。

市場は形状によって3つのカテゴリーに分けられます：軟膏、ゲル、クリームです。軟膏は、接触時間が長く保湿性が高いため、酵素創傷デブリードマンに最も広く使用されています。ゲルは塗布が簡単で吸収が早いことから人気を集めています。クリームはあまり一般的ではありませんが、創傷のタイプによっては好まれます。

酵素創傷デブリードマン市場：地域別分析

酵素創傷デブリードマン市場は地域力学が明瞭で、北米は高度な医療インフラ、高額な医療費、創傷ケアにおける酵素製品の普及によりリードしています。特に米国では、数百万人が罹患している糖尿病などの慢性疾患の罹患率が上昇していることから、酵素創傷デブリードマン療法に対する需要が高まっています。欧州もこれに続き、ドイツ、フランス、英国などの国々では、強固な医療システムと慢性創傷管理に対する意識の高まりにより、酵素創傷治療の採用が増加しています。アジア太平洋地域は、糖尿病性創傷やその他の慢性疾患の有病率が急増している中国やインドのような国々で、医療アクセスが向上していることが要因となって、主要な成長地域として浮上しています。さらに、ラテンアメリカや中東・アフリカの政府は創傷治療の改善に投資しており、これらの地域に大きな市場機会をもたらしています。

酵素創傷デブリードマン市場：競合情勢

酵素創傷デブリードマン市場は競争が激しく、複数の主要企業が技術革新、製品開拓、戦略的提携に注力しています。MediWound社、Smith &Nephew社、Integra LifeSciences社などの主要企業が市場を独占しており、NexobridやCollagenase Santylなどの酵素創傷デブリードマン製品を提供しています。これらの企業は製品の有効性を高め、創傷治療におけるアンメットニーズに対応するため、臨床試験や調査に投資しています。DeRoyal IndustriesやBioMondeも重要なプレーヤーで、慢性創傷管理のための酵素ソリューションを提供しています。病院や医療機関との提携は一般的であり、これによって企業は事業範囲を拡大し、治療成果を向上させることができます。さらに、中小企業や新興企業は天然酵素をベースとした製剤に着目し、より持続可能で費用対効果の高い創傷デブリードマンアプローチをターゲットに、市場の革新を進めています。競合戦略にはM&Aも含まれ、各社はポートフォリオを拡大し、特に新興市場での存在感を高めています。

目次

第1章 酵素創傷デブリードマン市場の概要

  • 調査範囲
  • 市場推定期間

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 酵素創傷デブリードマンの主な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 酵素創傷デブリードマン市場：産業分析

  • PEST分析
  • ポーターのファイブフォース分析
  • 市場成長の見通し：マッピング
  • 規制体制の分析

第5章 酵素創傷デブリードマン市場：高まる地政学的緊張の影響

  • COVID-19パンデミックの影響
  • ロシア・ウクライナ戦争の影響
  • 中東紛争の影響

第6章 酵素創傷デブリードマンの市場情勢

  • 酵素創傷デブリードマンの市場シェア分析 (2023年)
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 酵素創傷デブリードマン市場：酸素の種類別

  • 概要
    • セグメント別シェア分析：酸素の種類別
    • コラーゲナーゼベース
    • パパインベース
    • トリプシンベース
    • タンパク質分解酵素

第8章 酵素創傷デブリードマン市場：形状別

  • 概要
    • セグメント別シェア分析：形状別
    • 軟膏
    • ゲル
    • クリーム

第9章 酵素創傷デブリードマン市場：創傷の種類別

  • 概要
    • セグメント別シェア分析：創傷の種類別
    • 慢性創傷
    • 急性創傷
    • 火傷

第10章 酵素創傷デブリードマン市場：エンドユーザー別

  • 概要
    • セグメント別シェア分析：エンドユーザー別
    • 病院
    • クリニック
    • 外来手術センター (ASC)

第11章 酵素創傷デブリードマン市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋 (APAC)
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析：酵素創傷デブリードマン業界

  • 競合ダッシュボード
    • 競合ベンチマーク
    • 競合ポジショニング
  • 企業プロファイル
    • 3M Company
    • Advanced BioHealing Inc.
    • B. Braun Melsungen AG
    • Baxter International Inc.
    • Cardinal Health, Inc.
    • Coloplast A/S
    • ConvaTec Group PLC
    • Derma Sciences, Inc.
    • Integra LifeSciences Corporation
    • Medline Industries, LP
    • Molnlycke Health Care AB
    • Organogenesis Inc.
    • Sanofi SA
    • Smith &Nephew plc
    • Stryker Corporation
    • Zimmer Biomet Holdings, Inc.
    • Others

第13章 アナリストの全方位展望

目次
Product Code: ANV4371

REPORT HIGHLIGHT

Enzymatic Wound Debridement Market size was valued at USD 877 Million in 2023, expanding at a CAGR of 6.1% from 2024 to 2032.

The Enzymatic Wound Debridement Market focuses on the use of enzymatic agents to remove dead tissue from chronic and acute wounds, promoting faster healing. Enzymatic debridement is a preferred method due to its non-invasive nature and ability to preserve healthy tissue, with products like Collagenase showing a significant impact on wound care outcomes. The increasing prevalence of chronic conditions, such as diabetes, which affects over 460 million people globally, is driving the demand for effective wound care solutions. However, the market faces challenges such as high treatment costs and limited reimbursement policies in certain regions. Opportunities lie in the development of more affordable, targeted enzymatic products and expanding access to wound care in emerging markets, where the need for efficient wound management is growing due to rising incidences of injuries and infections. Additionally, partnerships between wound care companies and healthcare providers are helping expand the reach of enzymatic debridement therapies.

Enzymatic Wound Debridement Market- Market Dynamics

Rising Prevalence of Chronic Diseases Fuels Growth in the Enzymatic Wound Debridement Market

The Enzymatic Wound Debridement Market is experiencing significant growth due to the increasing prevalence of chronic diseases such as diabetes, which affects over 460 million people worldwide according to the International Diabetes Federation. Enzymatic wound debridement, which utilizes products like Collagenase to selectively remove necrotic tissue, is gaining traction due to its ability to promote faster healing with minimal tissue damage. In the U.S., diabetic foot ulcers, a common complication of diabetes, affect about 15% of diabetic patients, increasing the demand for effective wound care treatments. Additionally, advancements in enzymatic formulations are enhancing the efficacy of debridement products, making them more accessible and affordable. Governments and healthcare organizations are also focusing on improving wound care standards, with initiatives in Europe aimed at increasing awareness and access to advanced treatments. This growing focus on chronic disease management and effective wound healing therapies is driving the expansion of the enzymatic wound debridement market.

Enzymatic Wound Debridement Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.1% over the forecast period (2024-2032)

Based on Enzyme Type segmentation, Collagenase-Based was predicted to show maximum market share in the year 2023

Based on Form segmentation, Ointments were the leading type in 2023

Based on Wound Type segmentation, Chronic Wounds was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Enzymatic Wound Debridement Market- Segmentation Analysis:

The Global Enzymatic Wound Debridement Market is segmented based on Enzyme Type, Form, Wound Type, End-User, and Region.

The market is divided into four categories based on Enzyme Type: Collagenase-Based, Papain-Based, Trypsin-Based, and Proteolytic Enzymes. Collagenase-based enzymatic debridement leads the market due to its effectiveness in breaking down collagen in necrotic tissue. Papain-based enzymes follow, offering a gentler alternative for wound care. Proteolytic Enzymes and Trypsin-Based products are less commonly used but are growing in application.

The market is divided into three categories based on Form: Ointments, Gels, and Creams. Ointments are the most widely used form in enzymatic wound debridement due to their prolonged contact time and moisture retention properties. Gels are gaining popularity for their ease of application and quick absorption. Creams are less common but are preferred for certain wound types.

Enzymatic Wound Debridement Market- Geographical Insights

The Enzymatic Wound Debridement Market exhibits distinct regional dynamics, with North America leading due to its advanced healthcare infrastructure, high healthcare expenditure, and widespread use of enzymatic products in wound care. The United States, in particular, sees a high demand for enzymatic debridement therapies, driven by the rising incidence of chronic conditions such as diabetes, which affects millions of people. Europe follows closely, with countries like Germany, France, and the UK seeing increasing adoption of enzymatic wound care due to robust healthcare systems and rising awareness of chronic wound management. The Asia-Pacific region is emerging as a key growth area, fueled by the rising healthcare access in countries like China and India, where the prevalence of diabetic wounds and other chronic conditions is growing rapidly. Additionally, governments in Latin America and the Middle East and Africa are investing in improving wound care treatments, presenting significant market opportunities in these regions.

Enzymatic Wound Debridement Market- Competitive Landscape:

The Enzymatic Wound Debridement Market is competitive, with several key players focusing on innovation, product development, and strategic partnerships. Leading companies like MediWound, Smith & Nephew, and Integra LifeSciences dominate the market, offering enzymatic debridement products such as Nexobrid and Collagenase Santyl. These companies are investing in clinical trials and research to enhance the efficacy of their products and address unmet needs in wound care. DeRoyal Industries and BioMonde are also significant players, providing enzymatic solutions for chronic wound management. Collaborations with hospitals and healthcare institutions are common, enabling companies to expand their reach and improve treatment outcomes. Additionally, smaller players and startups are innovating in the market by focusing on natural enzyme-based formulations, targeting a more sustainable and cost-effective approach to wound debridement. Competitive strategies include mergers and acquisitions, allowing companies to broaden their portfolios and strengthen market presence, particularly in emerging markets.

Recent Developments:

In July 2024, Molnlycke Health Care announced a $15 million investment in MediWound Ltd., focusing on next-generation enzymatic therapeutics for wound debridement. This partnership aims to enhance wound care solutions and improve patient outcomes through innovative enzymatic treatments.

In January 2023, SolasCure reported promising pre-clinical results for its Aurase Wound Gel, an enzymatic debridement product derived from a maggot enzyme. This gel aims to enhance chronic wound cleaning and is currently undergoing clinical trials, with results anticipated soon.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ENZYMATIC WOUND DEBRIDEMENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • 3M Company
  • Advanced BioHealing Inc.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Cardinal Health, Inc.
  • Coloplast A/S
  • ConvaTec Group PLC
  • Derma Sciences, Inc.
  • Integra LifeSciences Corporation
  • Medline Industries, LP
  • Molnlycke Health Care AB
  • Organogenesis Inc.
  • Sanofi S.A.
  • Smith & Nephew plc
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
  • Others

GLOBAL ENZYMATIC WOUND DEBRIDEMENT MARKET, BY ENZYME TYPE- MARKET ANALYSIS, 2019 - 2032

  • Collagenase-Based
  • Papain-Based
  • Trypsin-Based
  • Proteolytic Enzymes

GLOBAL ENZYMATIC WOUND DEBRIDEMENT MARKET, BY FORM- MARKET ANALYSIS, 2019 - 2032

  • Ointments
  • Gels
  • Creams

GLOBAL ENZYMATIC WOUND DEBRIDEMENT MARKET, BY WOUND TYPE- MARKET ANALYSIS, 2019 - 2032

  • Chronic Wounds
  • Acute Wounds
  • Burns

GLOBAL ENZYMATIC WOUND DEBRIDEMENT MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers (ASCs)

GLOBAL ENZYMATIC WOUND DEBRIDEMENT MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Enzymatic Wound Debridement Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Enzymatic Wound Debridement Market Snippet by Enzyme Type
    • 2.1.2. Enzymatic Wound Debridement Market Snippet by Form
    • 2.1.3. Enzymatic Wound Debridement Market Snippet by Wound Type
    • 2.1.4. Enzymatic Wound Debridement Market Snippet by End-User
    • 2.1.5. Enzymatic Wound Debridement Market Snippet by Country
    • 2.1.6. Enzymatic Wound Debridement Market Snippet by Region
  • 2.2. Competitive Insights

3. Enzymatic Wound Debridement Key Market Trends

  • 3.1. Enzymatic Wound Debridement Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Enzymatic Wound Debridement Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Enzymatic Wound Debridement Market Opportunities
  • 3.4. Enzymatic Wound Debridement Market Future Trends

4. Enzymatic Wound Debridement Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Enzymatic Wound Debridement Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Enzymatic Wound Debridement Market Landscape

  • 6.1. Enzymatic Wound Debridement Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Enzymatic Wound Debridement Market - By Enzyme Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Enzyme Type, 2023 & 2032 (%)
    • 7.1.2. Collagenase-Based
    • 7.1.3. Papain-Based
    • 7.1.4. Trypsin-Based
    • 7.1.5. Proteolytic Enzymes

8. Enzymatic Wound Debridement Market - By Form

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Form, 2023 & 2032 (%)
    • 8.1.2. Ointments
    • 8.1.3. Gels
    • 8.1.4. Creams

9. Enzymatic Wound Debridement Market - By Wound Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Wound Type, 2023 & 2032 (%)
    • 9.1.2. Chronic Wounds
    • 9.1.3. Acute Wounds
    • 9.1.4. Burns

10. Enzymatic Wound Debridement Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Form, 2023 & 2032 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Clinics
    • 10.1.4. Ambulatory Surgical Centers (ASCs)

11. Enzymatic Wound Debridement Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Enzymatic Wound Debridement Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Enzymatic Wound Debridement Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Enzymatic Wound Debridement Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Enzymatic Wound Debridement Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Enzymatic Wound Debridement Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Enzymatic Wound Debridement Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. 3M Company
    • 12.2.2. Advanced BioHealing Inc.
    • 12.2.3. B. Braun Melsungen AG
    • 12.2.4. Baxter International Inc.
    • 12.2.5. Cardinal Health, Inc.
    • 12.2.6. Coloplast A/S
    • 12.2.7. ConvaTec Group PLC
    • 12.2.8. Derma Sciences, Inc.
    • 12.2.9. Integra LifeSciences Corporation
    • 12.2.10. Medline Industries, LP
    • 12.2.11. Molnlycke Health Care AB
    • 12.2.12. Organogenesis Inc.
    • 12.2.13. Sanofi S.A.
    • 12.2.14. Smith & Nephew plc
    • 12.2.15. Stryker Corporation
    • 12.2.16. Zimmer Biomet Holdings, Inc.
    • 12.2.17. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us